| 书目名称 | Personalized Medicine as Innovation |
| 副标题 | What Can Germany Lea |
| 编辑 | Katharina Kichko |
| 视频video | |
| 概述 | Publication in the field of economic sciences.Includes supplementary material: |
| 丛书名称 | Gesundheitsmanagement und Gesundheitsökonomik |
| 图书封面 |  |
| 描述 | Katharina Kichko supports the first Personalized Medicine learnings as she provides an approach overview in general as well as reimbursement and regulatory policies in particular. In focus stays analysis of the current Personalized Medicine in the U.S. and Germany as well as its preconditions for a wider implementation in the medical practice. Results have shown that the U.S. – as early knower – have the most projects as well as personalized drugs and therapies, while Germany – as a follower – has a significant number of projects and personalized products and more to come in future. |
| 出版日期 | Book 2019 |
| 关键词 | Personalized Medicine; Individualized Medicine; medical trends; personalized drug; pharmacogenetic test; |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-658-27843-4 |
| isbn_softcover | 978-3-658-27842-7 |
| isbn_ebook | 978-3-658-27843-4Series ISSN 2523-7667 Series E-ISSN 2523-7675 |
| issn_series | 2523-7667 |
| copyright | Springer Fachmedien Wiesbaden GmbH, part of Springer Nature 2019 |
发表于 2025-3-21 19:02:15
